Accelerate Diagnostics
AXDX
#11270
Rank
C$1.23 M
Marketcap
C$0.04876
Share price
0.00%
Change (1 day)
-96.74%
Change (1 year)

Earnings for Accelerate Diagnostics (AXDX)

Earnings in 2024 (TTM): -C$50.6 Million

According to Accelerate Diagnostics's latest financial reports the company's current earnings are C$11.69 Million. , an increase over its 2023 earnings that were of -C$76.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Accelerate Diagnostics from 1998 to 2024

Annual earnings

Year Earnings Change
2024 -C$53.06 Million-30.23%
2023 -C$76.04 Million-10.11%
2022 -C$84.6 Million-5.02%
2021 -C$89.07 Million-0.87%
2020 -C$89.85 Million-10.7%
2019 -C$0.11 Billion-10.05%
2018 -C$0.12 Billion22.77%
2017 -C$91.12 Million-4%
2016 -C$94.91 Million47.64%
2015 -C$64.29 Million42.74%
2014 -C$45.04 Million105.26%
2013 -C$21.94 Million
2011 -C$1.7 Million-182.9%
2010 C$2.05 M-219.16%
2009 -C$1.73 Million6.65%
2008 -C$1.62 Million-40.67%
2007 -C$2.72 Million14.69%
2006 -C$2.38 Million399.94%
2005 -C$0.48 Million
2001 -C$1.65 Million-52.29%
2000 -C$3.45 Million53.4%
1999 -C$2.25 Million-282.93%
1998 C$1.22 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
C$11.32 B-21,451.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
C$2.14 B-4,143.79%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
C$0.68 B-1,382.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
C$56.06 M-205.69%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
-C$0.23 Billion 328.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
C$1.89 B-3,668.59%๐Ÿ‡บ๐Ÿ‡ธ USA